‘Outstanding’ 2014 for Celgene as myeloma drugs soar

Posted: January 29th, 2015  |  Company/topic: Celgene
Website:
'Outstanding' 2014 for Celgene as myeloma drugs soar…

Celgene says 2015 off to strong start; key growth drivers in place

Posted: January 29th, 2015  |  Company/topic: Celgene
Website:
Jan 29 (Reuters) - Celgene Corp on Thursday said early first quarter sales trends indicate the year is off to a strong start, and that it has growth drivers in place to meet or exceed its 2015 and lon…

New Celgene meds power forward, but Revlimid’s still the Big Kahuna

Posted: January 29th, 2015  |  Company/topic: Celgene
Website:
Celgene edged past analyst estimates for the fourth quarter and full year, with earnings of $3.71 per share and $7.67 billion in revenue for 2014. Its powerhouse remedy for multiple myeloma, Revlimid,…

BRIEF-Celgene says year off to strong start

Posted: January 29th, 2015  |  Company/topic: Celgene
Website:
Jan 29 (Reuters) - Celgene Corp : * Says early Q1 trends indicate strong start to year * Says plans to initiate 8 new phase i clinical programs in 2015 * Says received Revlimid reimbursement approval…